Decoding Aging through iPSC Reprogramming: Advances and Challenges

重编程 解码方法 医学 计算机科学 生物 遗传学 电信 细胞
作者
Ruilin Li,Yunzeng Zou,Sheng Kang
出处
期刊:Aging and Disease [Buck Institute for Research on Aging]
被引量:1
标识
DOI:10.14336/ad.2025.0438
摘要

Aging is characterized by cellular senescence and increased susceptibility to age-related diseases. Induced pluripotent stem cell (iPSC) technology demonstrates the potential to reverse aging hallmarks, including telomere attrition, mitochondrial dysfunction, and oxidative stress. Reprogramming somatic cells using factors such as Oct4, Sox2, Klf4, and c-Myc (OSKM) restores pluripotency and reverses aging markers. Partial reprogramming, involving transient OSKM expression, rejuvenates cells by resetting epigenetic clocks, reducing senescence-associated secretory phenotypes (SASPs), and improving mitochondrial function, as evidenced by lifespan extension in progeroid mouse models. These advancements facilitate disease modeling and autologous therapies for neurodegeneration, etc. Critical challenges, including tumorigenicity risks associated with oncogenic reprogramming factors, have been mitigated through non-integrative delivery systems (e.g., mRNA, small molecules) and suicide genes. Persistent epigenetic memory and incomplete reprogramming impede iPSC differentiation, but CRISPR-based tools (e.g., dCas9-DNMT3A, CRISPRoff) allow precise epigenetic editing to erase residual somatic signatures. Variability in iPSC quality, influenced by cell source and culture conditions, necessitates standardized protocols and CRISPR-enhanced quality control. Ethical considerations, such as informed consent and genetic discrimination, highlight the need for governance frameworks that align innovation with societal values. Subsequent priorities include optimizing reprogramming efficiency, validating safety in preclinical models, and translating findings into therapies for age-related disorders. In conclusion, iPSC and CRISPR technologies collectively present transformative strategies to delay aging and restore cellular vitality, paving the way for rejuvenation therapies. Future studies should focus on improving the reprogramming efficiency, minimizing the risk of tumorigenicity, and exploring the optimized CRISPR-based epigenetic editing technique.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Jun的应助被科研通管家采纳,获得10
刚刚
bkagyin的应助被科研通管家采纳,获得10
刚刚
刚刚
小Q完成签到,获得积分10
1秒前
Orange的应助被开心德地采纳,获得10
2秒前
如风随水的应助被aaaaaaaa采纳,获得10
2秒前
雪白萤完成签到 ,获得积分10
3秒前
3秒前
徐小帅完成签到,获得积分10
3秒前
可爱的函函的应助被单薄冰安采纳,获得10
3秒前
3秒前
东方不败完成签到 ,获得积分20
3秒前
4秒前
承承的应助被敏静采纳,获得10
4秒前
科研通AI6.4的应助被Asuka采纳,获得30
5秒前
舒心的灵枫完成签到,获得积分10
6秒前
Leo发布了新的文献求助10
6秒前
6秒前
yu发布了新的文献求助30
7秒前
cdercder的应助被谋勇兼备采纳,获得30
7秒前
Atlantis30发布了新的文献求助10
7秒前
汉堡包的应助被小Q采纳,获得10
8秒前
gao完成签到 ,获得积分10
8秒前
10秒前
Hanayu完成签到 ,获得积分0
11秒前
11秒前
啵子发布了新的文献求助10
12秒前
鲨鱼辣椒完成签到,获得积分10
12秒前
小熊波比完成签到,获得积分10
12秒前
CipherSage的应助被喵喵呜喵喵采纳,获得10
14秒前
zhouzhou完成签到,获得积分10
14秒前
肽聚糖完成签到,获得积分10
15秒前
单薄冰安发布了新的文献求助10
15秒前
15秒前
33发布了新的文献求助10
15秒前
CodeCraft的应助被等待的博采纳,获得10
16秒前
18秒前
19秒前
上官若男的应助被wg采纳,获得10
20秒前
吕玉宁发布了新的文献求助10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188654
求助须知:如何正确求助?哪些是违规求助? 9576372
关于积分的说明 21847161
捐赠科研通 7786741
什么是DOI,文献DOI怎么找? 3435402
关于科研通互助平台的介绍 2559632
邀请新用户注册赠送积分活动 2482360